Key Laboratory of Breast Cancer in Shanghai, The Shanghai Key Laboratory of Medical Epigenetics, Key Laboratory of Medical Epigenetics and Metabolism, Shanghai Medical College, Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences, Cancer Institutes, Fudan University, Shanghai, 200032, China.
Cell Biol Toxicol. 2021 Apr;37(2):277-291. doi: 10.1007/s10565-020-09533-5. Epub 2020 May 29.
Uncoupling protein 1 (UCP1) has been implicated in ameliorating metabolic related disorders, of which most symptoms are risk factors for breast cancer. Here, we found that UCP1 was obviously downregulated in basal-like breast cancer (BLBC) and was positively correlated with improved survival. However, the underlying regulatory mechanisms remain largely unknown. Our studies showed that UCP1 inhibited tumor progression via suppressing aldehyde dehydrogenase (ALDH)-positive breast cancer stem cell (BCSC) population in BLBC. Furthermore, we found that UCP1 induced the upregulation of fructose bisphosphatase 1 (FBP1) which was previously blocked by Snail overexpression, and UCP1 decreased ALDH-positive BCSCs via FBP1-dependent metabolic rewiring, which could be reversed by Snail overexpression. In addition, breast cancer cells co-cultured with UCP1-deficient adipocytes had increased proportion of ALDH-positive BCSCs, indicating a potential protection role of UCP1 in tumor microenvironment. These results suggested that UCP1 suppressed BCSCs through inhibiting Snail-mediated repression of FBP1, and that upregulation of UCP1 might be a previously undescribed therapeutic strategy for combating breast cancer. Graphical abstract.
解偶联蛋白 1(UCP1)被认为可以改善与代谢相关的疾病,其中大多数症状都是乳腺癌的风险因素。在这里,我们发现 UCP1 在基底样乳腺癌(BLBC)中明显下调,并且与改善的生存相关。然而,其潜在的调控机制在很大程度上仍不清楚。我们的研究表明,UCP1 通过抑制 BLBC 中的醛脱氢酶(ALDH)阳性乳腺癌干细胞(BCSC)群来抑制肿瘤进展。此外,我们发现 UCP1 诱导果糖二磷酸酶 1(FBP1)的上调,而 Snail 的过表达先前会阻断这一过程,并且 UCP1 通过 FBP1 依赖性代谢重编程来减少 ALDH 阳性 BCSCs,这可以通过 Snail 的过表达来逆转。此外,与 UCP1 缺陷脂肪细胞共培养的乳腺癌细胞中 ALDH 阳性 BCSCs 的比例增加,表明 UCP1 在肿瘤微环境中具有潜在的保护作用。这些结果表明,UCP1 通过抑制 Snail 介导的 FBP1 抑制来抑制 BCSCs,并且 UCP1 的上调可能是一种以前未描述的对抗乳腺癌的治疗策略。